A prognostic model for platinum‐doublet as second‐line chemotherapy in advanced non‐small‐cell lung cancer patients

Poor prognosis of advanced non‐small‐cell lung cancer (NSCLC) patients and the promising therapeutic effect of platinum urge the oncologists to evaluate the role of platinum doublet as second‐line chemotherapy and establish the definition of platinum sensitivity in NSCLC. We retrospectively analyzed...

Descripción completa

Detalles Bibliográficos
Autores principales: Mo, Hongnan, Hao, Xuezhi, Liu, Yutao, Wang, Lin, Hu, Xingsheng, Xu, Jianping, Yang, Sheng, Xing, Puyuan, Shi, Youwu, Jia, Bo, Wang, Yan, Li, Junling, Wang, Hongyu, Wang, Ziping, Sun, Yan, Shi, Yuankai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924370/
https://www.ncbi.nlm.nih.gov/pubmed/26993156
http://dx.doi.org/10.1002/cam4.689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924370/
https://www.ncbi.nlm.nih.gov/pubmed/26993156
http://dx.doi.org/10.1002/cam4.689

Ejemplares similares